AACR logo

More articles from Therapeutic Discovery

Identification of a Natural Compound by Cell-Based Screening That Enhances Interferon Regulatory Factor-1 Activity and Causes Tumor Suppression
Jinbo Gao, Yujun Wang, Quanhua Xing, Jin Yan, Maheswari Senthil, Yasir Akmal, Claudia M. Kowolik, Julia Kang, David M. Lu, Ming Zhao, Zhixiu Lin, Christopher H.K. Cheng, M.L. Richard Yip, John H. Yim

Molecular Cancer Therapeutics Oct 2011, 10 (10) 1774-1783; DOI: 10.1158/1535-7163.MCT-11-0304
Telomere Targeting with a New G4 Ligand Enhances Radiation-Induced Killing of Human Glioblastoma Cells
Patrick Merle, Bertrand Evrard, Anne Petitjean, Jean-Marie Lehn, Marie-Paule Teulade-Fichou, Emmanuel Chautard, Anne De Cian, Lionel Guittat, Phong Lan Thao Tran, Jean-Louis Mergny, Pierre Verrelle, Andreï Tchirkov

Molecular Cancer Therapeutics Oct 2011, 10 (10) 1784-1795; DOI: 10.1158/1535-7163.MCT-10-0664
Antitumor Activity of a Recombinant Soluble Ectodomain of Mutant Human Fibroblast Growth Factor Receptor-2 IIIc
Ju Wang, Xue-ting Liu, Hui Huang, Gang Xiao, Zhi-you Zhou, Yang Chen, Zhi-hong Yu, Shui-lian He, An-an Chen, Ding-ding Wang, Ying He, Zhi-cheng Zhang, An Hong

Molecular Cancer Therapeutics Sep 2011, 10 (9) 1656-1666; DOI: 10.1158/1535-7163.MCT-11-0163
Nerve Growth Factor Links Oral Cancer Progression, Pain, and Cachexia
Yi Ye, Dongmin Dang, Jianan Zhang, Chi T. Viet, David K. Lam, John C. Dolan, Jennifer L. Gibbs, Brian L. Schmidt

Molecular Cancer Therapeutics Sep 2011, 10 (9) 1667-1676; DOI: 10.1158/1535-7163.MCT-11-0123
Human Monoclonal Antibody Fragments Binding to Insulin-like Growth Factors I and II with Picomolar Affinity
Qi Zhao, Yang Feng, Zhongyu Zhu, Dimiter S. Dimitrov

Molecular Cancer Therapeutics Sep 2011, 10 (9) 1677-1685; DOI: 10.1158/1535-7163.MCT-11-0281
Compensatory Pathways Induced by MEK Inhibition Are Effective Drug Targets for Combination Therapy against Castration-Resistant Prostate Cancer
Daniel Gioeli, Winfried Wunderlich, Judith Sebolt-Leopold, Stefan Bekiranov, Julia D. Wulfkuhle, Emanuel F. Petricoin, Mark Conaway, Michael J. Weber

Molecular Cancer Therapeutics Sep 2011, 10 (9) 1581-1590; DOI: 10.1158/1535-7163.MCT-10-1033
Mechanisms of Action of a Dual Cdc7/Cdk9 Kinase Inhibitor against Quiescent and Proliferating CLL Cells
Alessandro Natoni, Laura S. Murillo, Anna E. Kliszczak, Mark A. Catherwood, Alessia Montagnoli, Afshin Samali, Michael O'Dwyer, Corrado Santocanale

Molecular Cancer Therapeutics Sep 2011, 10 (9) 1624-1634; DOI: 10.1158/1535-7163.MCT-10-1119
Linear Chain PEGylated Recombinant Bacillus Thiaminolyticus Thiaminase I Enzyme Has Growth Inhibitory Activity against Lymphoid Leukemia Cell Lines
Abigail Daily, Shuqian Liu, Younsoo Bae, Saloni Bhatnagar, Jeffrey A. Moscow

Molecular Cancer Therapeutics Sep 2011, 10 (9) 1563-1570; DOI: 10.1158/1535-7163.MCT-11-0003
Transformation-Dependent Silencing of Tumor-Selective Apoptosis-Inducing TRAIL by DNA Hypermethylation Is Antagonized by Decitabine
Per Lund, Irina Kotova, Valérie Kedinger, Harshal Khanwalkar, Emilie Voltz, William C. Hahn, Hinrich Gronemeyer

Molecular Cancer Therapeutics Sep 2011, 10 (9) 1611-1623; DOI: 10.1158/1535-7163.MCT-11-0140
Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines
Frédéric R. Santer, Philipp P.S. Höschele, Su Jung Oh, Holger H.H. Erb, Jan Bouchal, Ilaria T. Cavarretta, Walther Parson, David J. Meyers, Philip A. Cole, Zoran Culig

Molecular Cancer Therapeutics Sep 2011, 10 (9) 1644-1655; DOI: 10.1158/1535-7163.MCT-11-0182

Main menu

User menu

Search

More articles from Therapeutic Discovery

Pages

Articles

Info for

About MCT